金黄色葡萄球菌毒力调控及减毒药物研究进展

doi:10.11843/j.issn.0366-6964.2025.04.011

摘要/Abstract

摘要：

金黄色葡萄球菌是一种重要的人兽共患病原菌，可引起多种感染性疾病，严重威胁人类和动物健康。金黄色葡萄球菌可产生毒素、黏附蛋白和免疫逃逸因子等多种毒力因子，且具有复杂的毒力调控网络。由于传统的抗生素治疗面临细菌耐药性等问题，开发靶向减弱或消除金黄色葡萄球菌毒力的新型减毒药物成为抗菌药物研发的新方向。本文综述了目前关于金黄色葡萄球菌毒力调控及减毒药物研究的最新进展，为全面理解金黄色葡萄球菌的致病机制和进一步研发减毒药物提供参考和科学依据。

关键词: 金黄色葡萄球菌, 毒力, 调控机制, 减毒药物

Abstract:

Staphylococcus aureus (S. aureus) is an important zoonotic pathogen capable of causing various infectious diseases, posing a serious threat to human and animal health. It produces multiple virulence factors such as toxins, adhesion proteins, and immune evasion factors, and possesses a complex regulatory network for virulence. Due to issues like antibiotic resistance faced by traditional antibiotic treatments, the development of novel drugs aimed at reducing or eliminating the virulence of S. aureus has become a new direction in antimicrobial drug development. This article provides a comprehensive review of the latest advances in the regulation of S. aureus virulence and the development of antivirulence drugs, offering a reference and scientific basis for understanding the pathogenic mechanisms of S. aureus and further research on antivirulence drugs.

Key words: Staphylococcus aureus, virulence, regulatory mechanisms, antivirulence drugs

中图分类号:

S852.611

吉星, 李俊, 王冉, 何涛. 金黄色葡萄球菌毒力调控及减毒药物研究进展[J]. 畜牧兽医学报, 2025, 56(4): 1594-1607.

JI Xing, LI Jun, WANG Ran, HE Tao. Research Progress on Virulence Regulation and Antivirulence Drugs of Staphylococcus aureus[J]. Acta Veterinaria et Zootechnica Sinica, 2025, 56(4): 1594-1607.

图/表 2

参考文献 125

1	田洪亮, 徐刘溢, 彭练慈, 等. 金黄色葡萄球菌病防治研究进展[J]. 微生物学报, 2023, 63 (12): 4441- 4450.
	TIAN H L , XU L Y , PENG L C , et al. Research progress in prevention and treatment of Staphylococcus aureus[J]. Acta Microbiologica Sinica, 2023, 63 (12): 4441- 4450.
2	CHEUNG G Y C , BAE J S , OTTO M . Pathogenicity and virulence of Staphylococcus aureus[J]. Virulence, 2021, 12 (1): 547- 569. doi: 10.1080/21505594.2021.1878688
3	DEHBANIPOUR R , GHALAVAND Z . Anti-virulence therapeutic strategies against bacterial infections: recent advances[J]. Germs, 2022, 12 (2): 262- 275. doi: 10.18683/germs.2022.1328
4	GOULIAN M . Two-component signaling circuit structure and properties[J]. Curr Opin Microbiol, 2010, 13 (2): 184- 189. doi: 10.1016/j.mib.2010.01.009
5	ZHENG L , YAN M , FAN F , et al. The essential walk histidine kinase and WalrK regulator differentially mediate autolysis of Staphylococcus aureus RN4220[J]. J Nat Sci, 2015, 1 (6): e111.
6	DOBIHAL G S , BRUNET Y R , FLORES-KIM J , et al. Homeostatic control of cell wall hydrolysis by the WalRK two-component signaling pathway in Bacillus subtilis[J]. Elife, 2019, 8, e52088. doi: 10.7554/eLife.52088
7	DUBRAC S , MSADEK T . Identification of genes controlled by the essential YycG/YycF two-component system of Staphylococcus aureus[J]. J. Bacteriol, 2004, 186 (4): 1175- 1181. doi: 10.1128/JB.186.4.1175-1181.2004
8	WU S , QIN B , DENG S , et al. CodY is modulated by YycF and affects biofilm formation in Staphylococcus aureus[J]. Front Microbiol, 2022, 13, 967567. doi: 10.3389/fmicb.2022.967567
9	WU S , ZHANG J , PENG Q , et al. The role of Staphylococcus aureus YycFG in gene regulation, biofilm organization and drug resistance[J]. Antibiotics (Basel), 2021, 10 (12): 1555. doi: 10.3390/antibiotics10121555
10	DELAUNÉ A , DUBRAC S , BLANCHET C , et al. The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response[J]. Infect Immun, 2012, 80 (10): 3438- 3453. doi: 10.1128/IAI.00195-12
11	GIRAUDO A T , RASPANTI C G , CALZOLARI A , et al. Characterization of a Tn551-mutant of Staphylococcus aureus defective in the production of several exoproteins[J]. Can J Microbiol, 1994, 40 (8): 677- 681. doi: 10.1139/m94-107
12	LIU Q , YEO W , BAE T . The SaeRS two-component system of Staphylococcus aureus[J]. Genes(Basel), 2016, 7 (10): 81.
13	SUN F , LI C , JEONG D , et al. In the Staphylococcus aureus two-component system sae, the response regulator SaeR binds to a direct repeat sequence and DNA binding requires phosphorylation by the sensor kinase SaeS[J]. J Bacteriol, 2010, 192 (8): 2111- 2127. doi: 10.1128/JB.01524-09
14	MAINIERO M , GOERKE C , GEIGER T , et al. Differential target gene activation by the Staphylococcus aureus two-component system saeRS[J]. J Bacteriol, 2010, 192 (3): 613- 623. doi: 10.1128/JB.01242-09
15	RAMUNDO M S , BELTRAME C O , BOTELHO A M N , et al. A unique SaeS allele overrides cell-density dependent expression of saeR and lukSF-PV in the ST30-SCCmecIV lineage of CA-MRSA[J]. Int J Med Microbiol, 2016, 306 (6): 367- 380. doi: 10.1016/j.ijmm.2016.05.001
16	BAROJA M L , HERFST C A , KASPER K J , et al. The SaeRS two-component system is a direct and dominant transcriptional activator of toxic shock syndrome toxin 1 in Staphylococcus aureus[J]. J Bacteriol, 2016, 198 (19): 2732- 2742. doi: 10.1128/JB.00425-16
17	KATO F , KADOMOTO N , IWAMOTO Y , et al. Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus[J]. Infect Immun, 2011, 79 (4): 1660- 1670. doi: 10.1128/IAI.00872-10
18	WITTEKIND M A , BRIAUD P , SMITH J L , et al. The small protein ScrA influences Staphylococcus aureus virulence-related processes via the SaeRS system[J]. Microbiol Spectr, 2023, 11 (3): e0525522. doi: 10.1128/spectrum.05255-22
19	FOURNIER B , HOOPER D C . A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus[J]. J Bacteriol, 2000, 182 (14): 3955- 3964. doi: 10.1128/JB.182.14.3955-3964.2000
20	WALKER J N , CROSBY H A , SPAULDING A R , et al. The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis[J]. PLoS Pathog, 2013, 9 (12): e1003819. doi: 10.1371/journal.ppat.1003819
21	RADIN J N , KELLIHER J L , PÁRRAGA SOLÓRZANO P K , et al. The two-component system ArlRS and alterations in metabolism enable Staphylococcus aureus to resist calprotectin-induced manganese starvation[J]. PLoS Pathog, 2016, 12 (11): e1006040. doi: 10.1371/journal.ppat.1006040
22	PÁRRAGA SOLÓRZANO P K , YAO J , ROCK C O , et al. Disruption of glycolysis by nutritional immunity activates a Two-Component System that coordinates a metabolic and antihost response by Staphylococcus aureus[J]. MBio, 2019, 10 (4): e01321- 19.
23	CROSBY H A , TIWARI N , KWIECINSKI J M , et al. The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA[J]. Mol Microbiol, 2020, 113 (1): 103- 122. doi: 10.1111/mmi.14404
24	CROSBY H A , SCHLIEVERT P M , MERRIMAN J A , et al. The Staphylococcus aureus global regulator MgrA modulates clumping and virulence by controlling surface protein expression[J]. PLoS Pathog, 2016, 12 (5): e1005604. doi: 10.1371/journal.ppat.1005604
25	SUN F , JI Q , JONES M B , et al. AirSR, a[J]. J Am Chem Soc, 2012, 134 (1): 305- 314. doi: 10.1021/ja2071835
26	HALL J W , YANG J , GUO H , et al. The AirSR two-component system contributes to Staphylococcus aureus survival in human blood and transcriptionally regulates sspABC operon[J]. Front Microbiol, 2015, 6, 682.
27	SUN H , YANG Y , XUE T , et al. Modulation of cell wall synthesis and susceptibility to vancomycin by the two-component system AirSR in Staphylococcus aureus NCTC8325[J]. BMC Microbiol, 2013, 13, 286. doi: 10.1186/1471-2180-13-286
28	HALL J W , YANG J , GUO H , et al. The Staphylococcus aureus AirSR two-component system mediates reactive oxygen species resistance via transcriptional regulation of Staphyloxanthin production[J]. Infect Immun, 2017, 85 (2): e00838- 16.
29	TIWARI N , LÓPEZ-REDONDO M , MIGUEL-ROMERO L , et al. The SrrAB two-component system regulates Staphylococcus aureus pathogenicity through redox sensitive cysteines[J]. Proc Natl Acad Sci U S A, 2020, 117 (20): 10989- 10999. doi: 10.1073/pnas.1921307117
30	THROUP J P , ZAPPACOSTA F , LUNSFORD R D , et al. The srhSR gene pair from Staphylococcus aureus: genomic and proteomic approaches to the identification and characterization of gene function[J]. Biochemistry, 2001, 40 (34): 10392- 10401. doi: 10.1021/bi0102959
31	YARWOOD J M , MCCORMICK J K , SCHLIEVERT P M . Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus[J]. J Bacteriol, 2001, 183 (4): 1113- 1123. doi: 10.1128/JB.183.4.1113-1123.2001
32	WHITE M J , BOYD J M , HORSWILL A R , et al. Phosphatidylinositol-specific phospholipase C contributes to survival of Staphylococcus aureus USA300 in human blood and neutrophils[J]. Infect Immun, 2014, 82 (4): 1559- 1571. doi: 10.1128/IAI.01168-13
33	BLEUL L , FRANCOIS P , WOLZ C . Two-Component systems of S. aureus: signaling and sensing mechanisms[J]. Genes (Basel), 2021, 13 (1): 34. doi: 10.3390/genes13010034
34	LE K Y , OTTO M . Quorum-sensing regulation in staphylococci-an overview[J]. Front Microbiol, 2015, 6, 1174.
35	JENUL C , HORSWILL A R . Regulation of Staphylococcus aureus virulence[J]. Microbiol. Spectr, 2019, 7 (2)
36	VINODHINI V , KAVITHA M . Deciphering agr quorum sensing in Staphylococcus aureus: insights and therapeutic prospects[J]. Mol Biol Rep, 2024, 51 (1): 155. doi: 10.1007/s11033-023-08930-3
37	BALABAN N , GOLDKORN T , GOV Y , et al. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP)[J]. J Biol Chem, 2001, 276 (4): 2658- 2667. doi: 10.1074/jbc.M005446200
38	BOISSET S , GEISSMANN T , HUNTZINGER E , et al. Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism[J]. Genes Dev, 2007, 21 (11): 1353- 1366. doi: 10.1101/gad.423507
39	LE HUYEN K B , GONZALEZ C D , PASCREAU G , et al. A small regulatory RNA alters Staphylococcus aureus virulence by titrating RNAIII activity[J]. Nucleic Acids Res, 2021, 49 (18): 10644- 10656. doi: 10.1093/nar/gkab782
40	WILLIAMS P , HILL P , BONEV B , et al. Quorum-sensing, intra-and inter-species competition in the staphylococci[J]. Microbiology (Reading), 2023, 169 (8): 001381.
41	CHEUNG G Y C , JOO H , CHATTERJEE S S , et al. Phenol-soluble modulins--critical determinants of staphylococcal virulence[J]. FEMS Microbiol Rev, 2014, 38 (4): 698- 719. doi: 10.1111/1574-6976.12057
42	CHEUNG A L , NISHINA K A , TROTONDA M P , et al. The SarA protein family of Staphylococcus aureus[J]. Int J Biochem Cell Biol, 2008, 40 (3): 355- 361. doi: 10.1016/j.biocel.2007.10.032
43	MANNA A C , BAYER M G , CHEUNG A L . Transcriptional analysis of different promoters in the sar locus in Staphylococcus aureus[J]. J Bacteriol, 1998, 180 (15): 3828- 3836. doi: 10.1128/JB.180.15.3828-3836.1998
44	CHAN P F , FOSTER S J . Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus[J]. J Bacteriol, 1998, 180 (23): 6232- 6241. doi: 10.1128/JB.180.23.6232-6241.1998
45	STERBA K M , MACKINTOSH S G , BLEVINS J S , et al. Characterization of Staphylococcus aureus SarA binding sites[J]. J Bacteriol, 2003, 185 (15): 4410- 4417. doi: 10.1128/JB.185.15.4410-4417.2003
46	LOUGHRAN A J , ATWOOD D N , ANTHONY A C , et al. Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants[J]. Microbiologyopen, 2014, 3 (6): 897- 909. doi: 10.1002/mbo3.214
47	ANDREY D O , RENZONI A , MONOD A , et al. Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA[J]. J Bacteriol, 2010, 192 (22): 6077- 6085. doi: 10.1128/JB.00146-10
48	ORIOL C , CENGHER L , MANNA A C , et al. Expanding the Staphylococcus aureus SarA regulon to small RNAs[J]. MSystems, 2021, 6 (5): e0071321.
49	MANNA A , CHEUNG A L . Characterization of sarR, a modulator of sar expression in Staphylococcus aureus[J]. Infect Immun, 2001, 69 (2): 885- 896. doi: 10.1128/IAI.69.2.885-896.2001
50	REYES D , ANDREY D O , MONOD A , et al. Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus[J]. J Bacteriol, 2011, 193 (21): 6020- 6031. doi: 10.1128/JB.05436-11
51	MANNA A C , CHEUNG A L . SarU, a SarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus[J]. Infect Immun, 2003, 71 (1): 343- 353. doi: 10.1128/IAI.71.1.343-353.2003
52	SCHMIDT K A , MANNA A C , GILL S , et al. SarT, a repressor of alpha-hemolysin in Staphylococcus aureus[J]. Infect Immun, 2001, 69 (8): 4749- 4758. doi: 10.1128/IAI.69.8.4749-4758.2001
53	XUE T , ZHANG X , SUN H , et al. ArtR, a novel sRNA of Staphylococcus aureus, regulates α-toxin expression by targeting the 5' UTR of sarT mRNA[J]. Med Microbiol Immunol, 2014, 203 (1): 1- 12. doi: 10.1007/s00430-013-0307-0
54	TEGMARK K , KARLSSON A , ARVIDSON S . Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus[J]. Mol Microbiol, 2000, 37 (2): 398- 409. doi: 10.1046/j.1365-2958.2000.02003.x
55	SCHMIDT K A , MANNA A C , CHEUNG A L . SarT influences SarS expression in Staphylococcus aureus[J]. Infect Immun, 2003, 71 (9): 5139- 5148. doi: 10.1128/IAI.71.9.5139-5148.2003
56	ANDERSON E E , DYZENHAUS S , ILMAIN J K , et al. SarS is a repressor of Staphylococcus aureus bicomponent pore-forming Leukocidins[J]. Infect Immun, 2023, 91 (4): e0053222. doi: 10.1128/iai.00532-22
57	MCNAMARA P J , MILLIGAN-MONROE K C , KHALILI S , et al. Identification, cloning, and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus[J]. J Bacteriol, 2000, 182 (11): 3197- 3203. doi: 10.1128/JB.182.11.3197-3203.2000
58	TSENG C W , STEWART G C . Rot repression of enterotoxin B expression in Staphylococcus aureus[J]. J Bacteriol, 2005, 187 (15): 5301- 5309. doi: 10.1128/JB.187.15.5301-5309.2005
59	SAÏD-SALIM B , DUNMAN P M , MCALEESE F M , et al. Global regulation of Staphylococcus aureus genes by Rot[J]. J Bacteriol, 2003, 185 (2): 610- 619. doi: 10.1128/JB.185.2.610-619.2003
60	MANNA A C , RAY B . Regulation and characterization of rot transcription in Staphylococcus aureus[J]. Microbiology (Reading), 2007, 153 (Pt 5): 1538- 1545.
61	BENSON M A , LILO S , NYGAARD T , et al. Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins[J]. J Bacteriol, 2012, 194 (16): 4355- 4365. doi: 10.1128/JB.00706-12
62	LUONG T T , DUNMAN P M , MURPHY E , et al. Transcription profiling of the MgrA regulon in Staphylococcus aureus[J]. J Bacteriol, 2006, 188 (5): 1899- 1910. doi: 10.1128/JB.188.5.1899-1910.2006
63	GUPTA R K , LUONG T T , LEE C Y . RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing mRNA[J]. Proc Natl Acad Sci U S A, 2015, 112 (45): 14036- 14041. doi: 10.1073/pnas.1509251112
64	POHL K , FRANCOIS P , STENZ L , et al. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression[J]. J Bacteriol, 2009, 191 (9): 2953- 2963. doi: 10.1128/JB.01492-08
65	ROUX A , TODD D A , VELÁZQUEZ J V , et al. CodY-mediated regulation of the Staphylococcus aureus Agr system integrates nutritional and population density signals[J]. J Bacteriol, 2014, 196 (6): 1184- 1196. doi: 10.1128/JB.00128-13
66	IBBERSON C B , JONES C L , SINGH S , et al. Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor[J]. Infect Immun, 2014, 82 (10): 4253- 4264. doi: 10.1128/IAI.01710-14
67	MONTGOMERY C P , BOYLE-VAVRA S , ROUX A , et al. CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300[J]. Infect Immun, 2012, 80 (7): 2382- 2389. doi: 10.1128/IAI.06172-11
68	MAJERCZYK C D , DUNMAN P M , LUONG T T , et al. Direct targets of CodY in Staphylococcus aureus[J]. J Bacteriol, 2010, 192 (11): 2861- 2877. doi: 10.1128/JB.00220-10
69	BISCHOFF M , ENTENZA J M , GIACHINO P . Influence of a functional sigB operon on the global regulators sar and agr in Staphylococcus aureus[J]. J Bacteriol, 2001, 183 (17): 5171- 5179. doi: 10.1128/JB.183.17.5171-5179.2001
70	SENN M M , GIACHINO P , HOMEROVA D , et al. Molecular analysis and organization of the sigmaB operon in Staphylococcus aureus[J]. J Bacteriol, 2005, 187 (23): 8006- 8019. doi: 10.1128/JB.187.23.8006-8019.2005
71	GULDIMANN C , BOOR K J , WIEDMANN M , et al. Resilience in the face of uncertainty: Sigma factor B fine-tunes gene expression to support homeostasis in Gram-Positive bacteria[J]. Appl Environ Microbiol, 2016, 82 (15): 4456- 4469. doi: 10.1128/AEM.00714-16
72	ENTENZA J , MOREILLON P , SENN M M , et al. Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis[J]. Infect Immun, 2005, 73 (2): 990- 998. doi: 10.1128/IAI.73.2.990-998.2005
73	ANDREY D O , JOUSSELIN A , VILLANUEVA M , et al. Impact of the regulators SigB, Rot, SarA and sarS on the toxic shock tst promoter and TSST-1 expression in Staphylococcus aureus[J]. PLoS One, 2015, 10 (8): e0135579. doi: 10.1371/journal.pone.0135579
74	KUSCH K , HANKE K , HOLTFRETER S , et al. The influence of SaeRS and σ(B) on the expression of superantigens in different Staphylococcus aureus isolates[J]. Int J Med Microbiol, 2011, 301 (6): 488- 499. doi: 10.1016/j.ijmm.2011.01.003
75	AHMAD-MANSOUR N , LOUBET P , POUGET C , et al. Staphylococcus aureus toxins: An update on their pathogenic properties and potential treatments[J]. Toxins, 2021, 13 (10): 677. doi: 10.3390/toxins13100677
76	KONG C , NEOH H , NATHAN S . Targeting Staphylococcus aureus toxins: A potential form of anti-virulence therapy[J]. Toxins, 2016, 8 (3): 72. doi: 10.3390/toxins8030072
77	MAGYARICS Z , LESLIE F , BARTKO J , et al. Randomized, double-blind, placebo-controlled, single-ascending-dose study of the penetration of a monoclonal antibody combination (ASN100) targeting Staphylococcus aureus cytotoxins in the lung epithelial lining fluid of healthy volunteers[J]. Antimicrob Agents Chemother, 2019, 63 (8): e00350- 19.
78	LAVENTIE B , RADEMAKER H J , SALEH M , et al. Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins[J]. Proc Natl Acad Sci U S A, 2011, 108 (39): 16404- 16409. doi: 10.1073/pnas.1102265108
79	CARDOT-MARTIN E , CASALEGNO J S , BADIOU C , et al. α-Defensins partially protect human neutrophils against Panton-Valentine leukocidin produced by Staphylococcus aureus[J]. Lett Appl Microbiol, 2015, 61 (2): 158- 164. doi: 10.1111/lam.12438
80	DROZDOWSKI B , ZHOU Y , KLINE B , et al. Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B[J]. J Immune Based Ther Vaccines, 2010, 8, 9. doi: 10.1186/1476-8518-8-9
81	VARSHNEY A K , WANG X , SCHARFF M D , et al. Staphylococcal enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections[J]. J Infect Dis, 2013, 208 (12): 2058- 2066. doi: 10.1093/infdis/jit421
82	YANG X , BUONPANE R A , MOZA B , et al. Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats[J]. J Infect Dis, 2008, 198 (3): 344- 348. doi: 10.1086/589776
83	FENG J , SUN D , WANG L , et al. Biochanin a as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection[J]. World J Microbiol Biotechnol, 2021, 38 (1): 6.
84	REN X , GUO X , LIU C , et al. Natural flavone hispidulin protects mice from Staphylococcus aureus pneumonia by inhibition of α-hemolysin production via targeting AgrA(C)[J]. Microbiol Res, 2022, 261, 127071. doi: 10.1016/j.micres.2022.127071
85	AKSOY C S , AVCI F G , UGUREL O M , et al. Potentiating the activity of berberine for Staphylococcus aureus in a combinatorial treatment with thymol[J]. Microb Pathog, 2020, 149, 104542. doi: 10.1016/j.micpath.2020.104542
86	ZHANG M , LI H , AGYEKUMWAA A K , et al. Effects of citronellal on growth and enterotoxins production in Staphylococcus aureus ATCC 29213[J]. Toxicon, 2022, 213, 92- 98. doi: 10.1016/j.toxicon.2022.04.016
87	ELMESSERI R A , SALEH S E , ELSHERIF H M , et al. Staphyloxanthin as a potential novel target for deciphering promising anti-Staphylococcus aureus agents[J]. Antibiotics (Basel), 2022, 11 (3): 298. doi: 10.3390/antibiotics11030298
88	LIN F , LIU C , LIU Y , et al. Mechanism of action and inhibition of dehydrosqualene synthase[J]. Proc Natl Acad Sci U S A, 2010, 107 (50): 21337- 21342. doi: 10.1073/pnas.1010907107
89	CHEN F , DI H , WANG Y , et al. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence[J]. Nat Chem Biol, 2016, 12 (3): 174- 179. doi: 10.1038/nchembio.2003
90	GAO P , DAVIES J , KAO R Y T . Dehydrosqualene desaturase as a novel target for anti-virulence therapy against Staphylococcus aureus[J]. MBio, 2017, 8 (5): e01224- 17.
91	RAO L , XU Y , SHEN L , et al. Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and staphyloxanthin production[J]. Front Cell Infect Microbiol, 2022, 12, 1008289. doi: 10.3389/fcimb.2022.1008289
92	ELMESSERI R A , SALEH S E , GHOBISH S A , et al. Diclofenac and meloxicam exhibited anti-virulence activities targeting Staphyloxanthin production in methicillin-resistant Staphylococcus aureus[J]. Antibiotics (Basel), 2023, 12 (2): 277. doi: 10.3390/antibiotics12020277
93	TON-THAT H , MAZMANIAN S K , FAULL K F , et al. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. Sortase catalyzed in vitro transpeptidation reaction using LPXTG peptide and NH(2)-Gly(3) substrates[J]. J Biol Chem, 2000, 275 (13): 9876- 9881. doi: 10.1074/jbc.275.13.9876
94	YUE C , YUAN Z , XU G , et al. Structure-guided design, synthesis, and antivirulence assessment of covalent Staphylococcus aureus ortase a inhibitors[J]. J Med Chem, 2024, 67 (2): 1127- 1146. doi: 10.1021/acs.jmedchem.3c01615
95	YANG T , ZHANG T , GUAN X , et al. Tideglusib and its analogues as inhibitors of Staphylococcus aureus SrtA[J]. J Med Chem, 2020, 63 (15): 8442- 8457. doi: 10.1021/acs.jmedchem.0c00803
96	SONG W , WANG L , ZHAO Y , et al. Hibifolin, a natural sortase a inhibitor, attenuates the pathogenicity of Staphylococcus aureus and enhances the antibacterial activity of Cefotaxime[J]. Microbiol Spectr, 2022, 10 (4): e0095022. doi: 10.1128/spectrum.00950-22
97	ZHANG B , TENG Z , LI X , et al. Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and Alpha-Hemolysin[J]. Front Microbiol, 2017, 8, 1715. doi: 10.3389/fmicb.2017.01715
98	SONG W , WANG L , JIN M , et al. Punicalagin, an inhibitor of Sortase A, is a promising therapeutic drug to combat methicillin-resistant Staphylococcus aureus infections[J]. Antimicrob Agents Chemother, 2022, 66 (6): e0022422. doi: 10.1128/aac.00224-22
99	WANG L , WANG G , QU H , et al. Taxifolin, an inhibitor of sortase A, interferes with the adhesion of methicillin-resistant Staphylococcal aureus[J]. Front Microbiol, 2021, 12, 686864. doi: 10.3389/fmicb.2021.686864
100	SEETHALAKSHMI P S , RAJEEV R , KIRAN G S , et al. Promising treatment strategies to combat Staphylococcus aureus biofilm infections: an updated review[J]. Biofouling, 2020, 36 (10): 1159- 1181.
101	FELIPE V , BRESER M L , BOHL L P , et al. Chitosan disrupts biofilm formation and promotes biofilm eradication in Staphylococcus species isolated from bovine mastitis[J]. Int J Biol Macromol, 2019, 126, 60- 67. doi: 10.1016/j.ijbiomac.2018.12.159
102	KONG C , CHEE C , RICHTER K , et al. Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162[J]. Sci Rep, 2018, 8 (1): 2758. doi: 10.1038/s41598-018-21141-2
103	YAP C H , TAY S T , CHEE C F . Indole derivative (um-3e) as an antimicrobial and antivirulence strategy for the prevention of Staphylococcus aureus biofilm-associated infections[J]. Int J Infect Dis, 2023, 130, S115- S116.
104	KUMAR P , LEE J , BEYENAL H , et al. Fatty acids as antibiofilm and antivirulence agents[J]. Trends Microbiol, 2020, 28 (9): 753- 768. doi: 10.1016/j.tim.2020.03.014
105	SELVARAJ A , VALLIAMMAI A , MUTHURAMALINGAM P , et al. Carvacrol Targets SarA and CrtM of methicillin-resistant Staphylococcus aureus to mitigate biofilm formation and staphyloxanthin synthesis: An in vitro and in vivo approach[J]. ACS Omega, 2020, 5 (48): 31100- 31114. doi: 10.1021/acsomega.0c04252
106	VIJAYAKUMAR K , BHARATHIDASAN V , MANIGANDAN V , et al. Quebrachitol inhibits biofilm formation and virulence production against methicillin-resistant Staphylococcus aureus[J]. Microb Pathog, 2020, 149, 104286. doi: 10.1016/j.micpath.2020.104286
107	ZHENG J , SHANG Y , WU Y , et al. Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus[J]. ACS Infect Dis, 2021, 7 (6): 1690- 1701. doi: 10.1021/acsinfecdis.1c00030
108	WANG H , SHI Y , CHEN J , et al. The antiviral drug efavirenz reduces biofilm formation and hemolysis by Staphylococcus aureus[J]. J Med Microbiol, 2021, 70 (10)
109	ZHENG J , SHANG Y , WU Y , et al. Loratadine inhibits Staphylococcus aureus virulence and biofilm formation[J]. IScience, 2022, 25 (2): 103731. doi: 10.1016/j.isci.2022.103731
110	NIELSEN A , MÅNSSON M , BOJER M S , et al. Solonamide B inhibits quorum sensing and reduces Staphylococcus aureus mediated killing of human neutrophils[J]. PLoS One, 2014, 9 (1): e84992. doi: 10.1371/journal.pone.0084992
111	SULLY E K , MALACHOWA N , ELMORE B O , et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance[J]. PLoS Pathog, 2014, 10 (6): e1004174. doi: 10.1371/journal.ppat.1004174
112	DALY S M , ELMORE B O , KAVANAUGH J S , et al. ω-Hydroxyemodin limits Staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation[J]. Antimicrob Agents Chemother, 2015, 59 (4): 2223- 2235. doi: 10.1128/AAC.04564-14
113	BROWN M M , KWIECINSKI J M , CRUZ L M , et al. Novel peptide from commensal staphylococcus simulans blocks methicillin-resistant Staphylococcus aureus quorum sensing and protects host skin from damage[J]. Antimicrob Agents Chemother, 2020, 64 (6)
114	ALONZO F R . Toward uncovering the complexities of bacterial interspecies communication and competition on the skin[J]. MBio, 2022, 13 (4): e0132022. doi: 10.1128/mbio.01320-22
115	LIN H , SONG L , ZHOU S , et al. A hybrid antimicrobial peptide targeting Staphylococcus aureus with a dual function of inhibiting quorum sensing signaling and an antibacterial effect[J]. J Med Chem, 2023, 66 (24): 17105- 17117. doi: 10.1021/acs.jmedchem.3c02027
116	MAHDALLY N H , GEORGE R F , KASHEF M T , et al. Staquorsin: A novel Staphylococcus aureus agr-mediated quorum sensing inhibitor impairing virulence in vivo without notable resistance development[J]. Front Microbiol, 2021, 12, 700494. doi: 10.3389/fmicb.2021.700494
117	LEE J , KIM Y , LEE J . Inhibition of Staphylococcus aureus biofilm formation and virulence factor production by petroselinic acid and other unsaturated c18 fatty acids[J]. Microbiol Spectr, 2022, 10 (3): e0133022. doi: 10.1128/spectrum.01330-22
118	PARSONS J B , KUKULA M , JACKSON P , et al. Perturbation of Staphylococcus aureus gene expression by the enoyl-acyl carrier protein reductase inhibitor AFN-1252[J]. Antimicrob Agents Chemother, 2013, 57 (5): 2182- 2190. doi: 10.1128/AAC.02307-12
119	LONG D R , MEAD J , HENDRICKS J M , et al. 18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene expression[J]. Antimicrob Agents Chemother, 2013, 57 (1): 241- 247. doi: 10.1128/AAC.01023-12
120	ARYA R , KIM T , YOUN J W , et al. Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus[J]. Front Cell Infect Microbiol, 2023, 13, 1268044. doi: 10.3389/fcimb.2023.1268044
121	DUFRESNE K , DIMAGGIO D J , MADUTA C S , et al. Discovery of an anti-virulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin 1 (TSST-1) production[J]. J Biol Chem, 2024, 300 (7): 107455. doi: 10.1016/j.jbc.2024.107455
122	GAO P , WEI Y , HOU S , et al. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus[J]. Emerg Microbes Infect, 2023, 12 (2): 2254415. doi: 10.1080/22221751.2023.2254415
123	OKADA A , IGARASHI M , OKAJIMA T , et al. Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth[J]. J Antibiot, 2010, 63 (2): 89- 94. doi: 10.1038/ja.2009.128
124	KWIECINSKI J M , JELANI D A , FUENTES E J , et al. Therapeutic inhibition of Staphylococcus aureus ArlRS two-component regulatory system blocks virulence[J]. Antimicrob Agents Chemother, 2022, 66 (7): e0018722. doi: 10.1128/aac.00187-22
125	WANG Z , WANG H , BAI J , et al. The Staphylococcus aureus ArlS kinase inhibitor tilmicosin has potent anti-biofilm activity in both static and flow conditions[J]. Microorganisms, 2024, 12 (2)

[1]	尤留超, 尹号, 陶政宇, 黄蓉, 付磊, 储岳峰. 布鲁氏菌毒力因子与胞内存活机制研究进展[J]. 畜牧兽医学报, 2025, 56(4): 1575-1593.
[2]	和晓兰, 赵艳坤, 孟璐, 刘慧敏, 高姣姣, 郑楠. 生牛乳中金黄色葡萄球菌异质性耐药及机制研究[J]. 畜牧兽医学报, 2025, 56(4): 1934-1946.
[3]	张燕敏, 刘帅, 滕战伟, 谢红兵, 夏小静, 贺永惠, 常美楠. 功能性寡糖缓解犊牛腹泻的机理研究进展[J]. 畜牧兽医学报, 2025, 56(3): 979-994.
[4]	李真亚, 刘洁, 李允, 王飞, 孔嫄嫄, 李泳, 贾荣玲. 猪肺炎支原体强弱毒株的生物学特性及比较基因组学分析[J]. 畜牧兽医学报, 2025, 56(2): 851-859.
[5]	王浩, 王世玉, 肖金龙, 沈珏, 潘天灵, 张靖松, 肖鹏, 高洪. 猪源大肠杆菌高致病性毒力岛结构基因进化分析及其对TNF/NF-κB通路的影响[J]. 畜牧兽医学报, 2025, 56(1): 392-403.
[6]	付红玉, 李玥, 崔晗, 李玖芝, 许琬雪, 王曦, 樊瑞锋. 长链酯酰辅酶A合成酶4介导铁死亡的发生机制[J]. 畜牧兽医学报, 2024, 55(9): 3792-3801.
[7]	王奇林, 曹润来, 王威阳, 张博, 刘志杰, 王晓旭. 狐狸流产胎儿体内肺炎克雷伯菌的分离鉴定及耐药性分析[J]. 畜牧兽医学报, 2024, 55(8): 3640-3648.
[8]	崔恒洁, 覃金珑, 朱志豪, 鲍雪, 栗绍文, 孟宪荣. 金黄色葡萄球菌对苯扎溴铵敏感性与生物被膜形成能力相关性分析[J]. 畜牧兽医学报, 2024, 55(8): 3669-3677.
[9]	王玮, 王景松, 郭亚男, 高乐, 王玲玲, 陈灿, 王健霖, 王建东, 马科, 李继东. 宁夏部分地区犊牛腹泻样本大肠杆菌分离菌株的毒力因子检测与分析[J]. 畜牧兽医学报, 2024, 55(7): 3261-3266.
[10]	余祖华, 高梦茹, 齐志颖, 张静雨, 何雷, 陈建, 丁轲. RNA结合蛋白ELAVL1的功能及其调控病毒复制的研究进展[J]. 畜牧兽医学报, 2024, 55(5): 1914-1925.
[11]	和晓兰, 赵艳坤, 孟璐, 刘慧敏, 高姣姣, 郑楠. 金黄色葡萄球菌异质性耐药研究进展[J]. 畜牧兽医学报, 2024, 55(4): 1432-1445.
[12]	宋艳, 袁永丰, 钱虹宇, 李鑫灿, 罗洪艳, 王芝英, 周作勇. 羊伪结核棒状杆菌的分离鉴定及部分生物学特性分析[J]. 畜牧兽医学报, 2024, 55(2): 680-687.
[13]	吴自豪, 蔡依龙, 陀海欣, 陈伟. 1株马乳源PVL⁺ST22型金黄色葡萄球菌致病性分析[J]. 畜牧兽医学报, 2024, 55(2): 718-726.
[14]	占乐杨, 苟婧萱, 张曼琪, 傅唯轩, 兰守信, 涂健, 王振宇, 邵颖, 宋祥军. T6SS效应蛋白Tae4对金黄色葡萄球菌和产单核细胞李氏杆菌的抑菌作用[J]. 畜牧兽医学报, 2024, 55(10): 4660-4669.
[15]	苑庆欣, 刘阔, 包旭华, 高东阳, 李鹤, 宋军, 周志新. 白屈菜红碱抗耐甲氧西林金黄色葡萄球菌作用机制研究[J]. 畜牧兽医学报, 2024, 55(10): 4670-4678.